Key facts
- This page summarizes William Resides's Form 3 filing for BIOREGENX, INC. (BRGX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 May 2024, 13:12.
William Resides - 08 Mar 2024 Form 3 Insider Report for BIOREGENX, INC. (BRGX)
- Reporting relationship
- CEO, Interim CFO, Director, 10%+ Owner
- Issuer ticker
- BRGX
- Reported as of
- 08 Mar 2024
- Net transaction value
- $0
- Reporting owner signature
- William Resides
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
William Resides filed Form 3 for BIOREGENX, INC. (BRGX) on 22 May 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FDIT
holding
Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 20,674,000
- Date
- 08 Mar 2024
- Ownership
- Direct
FDIT
holding
Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 197,864,944
- Date
- 08 Mar 2024
- Ownership
- Trustee of Wilshire Holdings Trust
FDIT
holding
Series A Preferred
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 112
- Date
- 08 Mar 2024
- Ownership
- Direct
FDIT
holding
Series A Preferred
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,008
- Date
- 08 Mar 2024
- Ownership
- Trustee of Wilshire Holdings Trust
* marks a reported price that did not pass the local price check.